ARCHIVES

FDA Approves Herceptin For HER2+ Metastatic Stomach Cancers

This article is from The Cancer Letter archive.

Vol. 36 No. 38 | October 22, 2010

Download PDF Visit The Full Archive

Related Articles

In Multi-Site Phase I Studies, No Investigator Sees All Toxicities

March 26, 2010

NIH Study Confirms Male Risk Factors For Breast Cancer

February 28, 2014

FDA Oncologic Drug Committee Agrees That “Kitty Fight” With NCI Should Be Negotiated

November 28, 1975

UT System (Again) Directs DePinho to Cure MD Anderson Faculty Angst

November 7, 2014

The Cancer Letter Offers FAX Delivery

January 7, 1994

Cornell, MSKCC, Rockefeller To collaborate In $160M Basic Biological Research Program.

June 30, 2000